Travere Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Heerma Peter | CHIEF COMMERCIAL OFFICER | Sale | 4,980 | $40.00 | $199,200 | 113,013 | Dec 24, 2025 |
| ROTE WILLIAM E. | Chief Research Officer | Option Exercise | 60,000 | $20.61 | $1,236,600 | 161,443 | Dec 24, 2025 |
| Inrig Jula | CHIEF MEDICAL OFFICER | Option Exercise | 15,000 | $8.93 | $133,950 | 103,787 | Dec 24, 2025 |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sale | 7,402 | $40.00 | $296,080 | 38,233 | Dec 24, 2025 |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sale | 2,910 | $36.00 | $104,760 | 45,635 | Dec 15, 2025 |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | Option Exercise | 20,000 | $16.23 | $324,600 | 112,083 | Dec 1, 2025 |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Option Exercise | 12,500 | $22.40 | $280,000 | 109,410 | Nov 4, 2025 |
| Coughlin Timothy | — | Option Exercise | 8,000 | $16.33 | $130,640 | 63,500 | Oct 31, 2025 |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | Gift | 1,078 | — | — | 117,993 | Oct 31, 2025 |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | Option Exercise | 27,128 | $15.46 | $419,399 | 446,301 | Oct 28, 2025 |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | Sale | 2,662 | $30.00 | $79,860 | 124,662 | Oct 28, 2025 |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | Gift | 891 | — | — | 127,324 | Sep 23, 2025 |
| REED ELIZABETH E | Chief Legal Officer and GC | Option Exercise | 10,000 | $19.08 | $190,800 | 99,878 | Sep 22, 2025 |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sale | 119 | $19.71 | $2,345 | 92,083 | Sep 3, 2025 |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sale | 470 | $17.31 | $8,136 | 92,656 | Aug 27, 2025 |
| Inrig Jula | CHIEF MEDICAL OFFICER | Sale | 815 | $14.65 | $11,940 | 88,787 | Jul 1, 2025 |
| Williams Brinkley Ruth | — | Award / Grant | 6,500 | — | — | 25,750 | May 15, 2025 |
| Squarer Ron | — | Award / Grant | 6,500 | — | — | 35,375 | May 15, 2025 |
| Poole Sandra | — | Award / Grant | 6,500 | — | — | 30,000 | May 15, 2025 |
| Orwin John A | — | Award / Grant | 6,500 | — | — | 35,375 | May 15, 2025 |
| Meckler Jeffrey A | — | Award / Grant | 6,500 | — | — | 87,500 | May 15, 2025 |
| LYONS GARY A | — | Award / Grant | 6,500 | — | — | 57,500 | May 15, 2025 |
| COUGHLIN TIMOTHY | — | Award / Grant | 6,500 | — | — | 55,500 | May 15, 2025 |
| Bruhn Suzanne Louise | — | Award / Grant | 6,500 | — | — | 28,750 | May 15, 2025 |
| Baynes Roy D. | — | Award / Grant | 6,500 | — | — | 37,500 | May 15, 2025 |
| REED ELIZABETH E | Chief Legal Officer and GC | Option Exercise | 4,920 | — | — | 94,402 | May 5, 2025 |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sale | 1,784 | $21.05 | $37,553 | 93,126 | May 2, 2025 |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | Sale | 18,924 | $21.05 | $398,350 | 419,173 | May 2, 2025 |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | Sale | 1,771 | $21.05 | $37,280 | 128,215 | May 2, 2025 |
| ROTE WILLIAM E. | Chief Research Officer | Sale | 3,198 | $21.05 | $67,318 | 100,241 | May 2, 2025 |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sale | 48 | $13.14 | $631 | 89,990 | Apr 11, 2025 |
| ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | Option Exercise | 8,000 | — | — | 103,719 | Feb 12, 2025 |
| REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | Option Exercise | 8,000 | — | — | 97,482 | Feb 12, 2025 |
| Inrig Jula | CHIEF MEDICAL OFFICER | Option Exercise | 8,000 | — | — | 92,170 | Feb 12, 2025 |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Option Exercise | 10,000 | $17.96 | $179,600 | 73,654 | Feb 11, 2025 |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | Sale | 11,375 | $24.04 | $273,455 | 419,173 | Feb 11, 2025 |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | Sale | 3,074 | $25.00 | $76,850 | 127,634 | Feb 10, 2025 |
| Baynes Roy D. | — | Sale | 10,000 | $22.00 | $220,000 | 31,000 | Feb 6, 2025 |
| ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | Award / Grant | 21,500 | — | — | 104,670 | Feb 3, 2025 |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | Award / Grant | 130,000 | — | — | 481,239 | Feb 3, 2025 |
| Inrig Jula | CHIEF MEDICAL OFFICER | Sale | 1,066 | $20.11 | $21,437 | 84,170 | Feb 3, 2025 |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | Award / Grant | 21,500 | — | — | 127,874 | Feb 3, 2025 |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | Award / Grant | 21,500 | — | — | 95,230 | Feb 3, 2025 |
| REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | Sale | 8,951 | $19.78 | $177,051 | 89,482 | Jan 31, 2025 |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sale | 3,348 | $20.12 | $67,362 | 63,654 | Jan 31, 2025 |
| Baynes Roy D. | — | Sale | 16,000 | $20.00 | $320,000 | 31,000 | Jan 23, 2025 |
| ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | Sale | 2,437 | $19.46 | $47,424 | 83,170 | Jan 22, 2025 |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | Sale | 10,736 | $19.46 | $208,923 | 351,239 | Jan 22, 2025 |
| REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | Sale | 2,437 | $19.46 | $47,424 | 76,933 | Jan 22, 2025 |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | Sale | 1,584 | $18.94 | $30,001 | 106,374 | Jan 22, 2025 |